Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.

Campos VJ, Mazzini GS, Juchem JF, Gurski RR.

J Gastrointest Surg. 2019 Nov 19. doi: 10.1007/s11605-019-04456-x. [Epub ahead of print]

PMID:
31745889
2.

Interaction of HSD11B1 and H6PD polymorphisms in subjects with type 2 diabetes are protective factors against obesity: a cross-sectional study.

Chedid MF, do Nascimento FV, de Oliveira FS, de Souza BM, Kruel CRP, Gurski RR, Canani LH, Crispim D, Gerchman F.

Diabetol Metab Syndr. 2019 Sep 23;11:78. doi: 10.1186/s13098-019-0474-2. eCollection 2019.

3.

Factors Associated to Abnormal Distal Esophageal Exposure to Acid and Esophagitis in Individuals Seeking Bariatric Surgery.

Mazzini GS, Madalosso CA, Campos GM, Khoraki J, Barão FR, Navarini D, Gurski RR.

Surg Obes Relat Dis. 2019 May;15(5):710-716. doi: 10.1016/j.soard.2019.01.031. Epub 2019 Feb 3.

PMID:
31010734
4.

Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis.

Mazzini GS, Khoraki J, Dozmorov M, Browning MG, Wijesinghe D, Wolfe L, Gurski RR, Campos GM.

J Gastrointest Surg. 2019 Jan;23(1):51-57. doi: 10.1007/s11605-018-3938-z. Epub 2018 Sep 11.

PMID:
30206765
5.

The 2018 ISDE achalasia guidelines.

Zaninotto G, Bennett C, Boeckxstaens G, Costantini M, Ferguson MK, Pandolfino JE, Patti MG, Ribeiro U Jr, Richter J, Swanstrom L, Tack J, Triadafilopoulos G, Markar SR, Salvador R, Faccio L, Andreollo NA, Cecconello I, Costamagna G, da Rocha JRM, Hungness ES, Fisichella PM, Fuchs KH, Gockel I, Gurski R, Gyawali CP, Herbella FAM, Holloway RH, Hongo M, Jobe BA, Kahrilas PJ, Katzka DA, Dua KS, Liu D, Moonen A, Nasi A, Pasricha PJ, Penagini R, Perretta S, Sallum RAA, Sarnelli G, Savarino E, Schlottmann F, Sifrim D, Soper N, Tatum RP, Vaezi MF, van Herwaarden-Lindeboom M, Vanuytsel T, Vela MF, Watson DI, Zerbib F, Gittens S, Pontillo C, Vermigli S, Inama D, Low DE.

Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy071.

PMID:
30169645
6.

Alternative therapies for GERD: a way to personalized antireflux surgery.

Rieder E, Riegler M, Simić AP, Skrobić OM, Bonavina L, Gurski R, Paireder M, Castell DO, Schoppmann SF.

Ann N Y Acad Sci. 2018 Dec;1434(1):360-369. doi: 10.1111/nyas.13851. Epub 2018 May 17.

PMID:
29774563
7.

The Impact of Gastric Bypass on Gastroesophageal Reflux Disease in Morbidly Obese Patients.

Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Mazzini G, Pereira Mda S.

Ann Surg. 2016 Jan;263(1):110-6. doi: 10.1097/SLA.0000000000001139.

PMID:
25607766
8.

Can different subsets of ineffective esophageal motility influence the outcome of nissen fundoplication?

Simić AP, Skrobić OM, Gurski RR, Šljukić VM, Ivanović NR, Peško PM.

J Gastrointest Surg. 2014 Oct;18(10):1723-9. doi: 10.1007/s11605-014-2607-0. Epub 2014 Aug 5.

PMID:
25091845
9.

Two separate modules of the conserved regulatory RNA AbcR1 address multiple target mRNAs in and outside of the translation initiation region.

Overlöper A, Kraus A, Gurski R, Wright PR, Georg J, Hess WR, Narberhaus F.

RNA Biol. 2014;11(5):624-40. Epub 2014 May 13.

10.

Gastrointestinal cancer metastasis.

Chen JL, Gurski RR, Takahashi K, Andersson R.

Gastroenterol Res Pract. 2012;2012:415498. doi: 10.1155/2012/415498. Epub 2012 Dec 22. No abstract available.

11.

Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Pretto G, Gurski RR, Binato M, Navarini D, Aguiar WW, Meurer L.

Dig Dis Sci. 2013 Jan;58(1):115-22. doi: 10.1007/s10620-012-2316-z. Epub 2012 Aug 9.

PMID:
22875307
12.

Ki-67 Antigen Overexpression Is Associated with the Metaplasia-Adenocarcinoma Sequence in Barrett's Esophagus.

Volkweis BS, Gurski RR, Meurer L, Pretto GG, Mazzini Gda S, Edelweiss MI.

Gastroenterol Res Pract. 2012;2012:639748. doi: 10.1155/2012/639748. Epub 2012 Jul 11.

13.

Hfq influences multiple transport systems and virulence in the plant pathogen Agrobacterium tumefaciens.

Wilms I, Möller P, Stock AM, Gurski R, Lai EM, Narberhaus F.

J Bacteriol. 2012 Oct;194(19):5209-17. doi: 10.1128/JB.00510-12. Epub 2012 Jul 20.

14.

Epidermal growth factor receptor expression in esophageal adenocarcinoma: relationship with tumor stage and survival after esophagectomy.

Navarini D, Gurski RR, Madalosso CA, Aita L, Meurer L, Fornari F.

Gastroenterol Res Pract. 2012;2012:941954. doi: 10.1155/2012/941954. Epub 2012 Jun 26.

15.

Impact of laparoscopic fundoplication for the treatment of laryngopharyngeal reflux: review of the literature.

Mazzini Gda S, Gurski RR.

Int J Otolaryngol. 2012;2012:291472. doi: 10.1155/2012/291472. Epub 2011 Dec 15.

16.

Is there an association between hiatal hernia and ineffective esophageal motility in patients with gastroesophageal reflux disease?

Conrado LM, Gurski RR, da Rosa AR, Simic AP, Callegari-Jacques SM.

J Gastrointest Surg. 2011 Oct;15(10):1756-61. doi: 10.1007/s11605-011-1619-2. Epub 2011 Aug 10.

PMID:
21830151
17.

Immunohistochemical overexpression of the p53 protein and Ki-67 (MIB-1) antigen in patients with GERD and chronic esophagitis.

Binato M, Fagundes R, Gurski R, Meurer L, Edelweiss MI.

Appl Immunohistochem Mol Morphol. 2010 May;18(3):236-43. doi: 10.1097/PAI.0b013e3181c49134.

PMID:
20414055
18.

The role of gastro-oesophageal pressure gradient and sliding hiatal hernia on pathological gastro-oesophageal reflux in severely obese patients.

Fornari F, Madalosso CA, Farré R, Gurski RR, Thiesen V, Callegari-Jacques SM.

Eur J Gastroenterol Hepatol. 2010 Apr;22(4):404-11. doi: 10.1097/MEG.0b013e328332f7b8.

PMID:
20110819
19.

Immunohistochemical evaluation for P53 and VEGF (Vascular Endothelial Growth Factor) is not prognostic for long term survival in end stage esophageal adenocarcinoma.

Cavazzola LT, Rosa AR, Schirmer CC, Gurski RR, Telles JP, Mielke F, Meurer L, Edelweiss MI, Kruel CD.

Rev Col Bras Cir. 2009 Feb;36(1):24-34.

20.

The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus.

Madalosso CA, Gurski RR, Callegari-Jacques SM, Navarini D, Thiesen V, Fornari F.

Ann Surg. 2010 Feb;251(2):244-8. doi: 10.1097/SLA.0b013e3181bdff20.

PMID:
20010088
21.

Clinical utility of endoscopy and barium swallow X-ray in the diagnosis of sliding hiatal hernia in morbidly obese patients: a study before and after gastric bypass.

Fornari F, Gurski RR, Navarini D, Thiesen V, Mestriner LH, Madalosso CA.

Obes Surg. 2010 Jun;20(6):702-8. doi: 10.1007/s11695-009-9971-y. Epub 2009 Sep 12.

PMID:
19756887
22.

Serum transferrin and serum prealbumin as markers of response to nutritional support in patients with esophageal cancer.

Guerra LT, Rosa AR, Romani RF, Gurski RR, Schirmer CC, Kruel CD.

Nutr Hosp. 2009 Mar-Apr;24(2):241-2. No abstract available.

PMID:
19593499
23.

The story beyond the Zenker's pouch.

Simić AP, Gurski RR, Pesko PM.

Acta Chir Iugosl. 2009;56(1):9-16. No abstract available.

PMID:
19504984
24.

Polylactic acid film versus acellular porcine small intestinal submucosa mesh in peritoneal adhesion formation in rats.

Costa RG, Lontra MB, Scalco P, Cavazzola LT, Gurski RR.

Acta Cir Bras. 2009 Mar-Apr;24(2):128-35.

25.

P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence.

Binato M, Gurski RR, Fagundes RB, Meurer L, Edelweiss MI.

Dis Esophagus. 2009;22(7):588-95. doi: 10.1111/j.1442-2050.2009.00953.x. Epub 2009 Mar 6.

PMID:
19302208
26.

Hospital discharge in the day following open Roux-en-Y gastric bypass: is it feasible and safe?

dos Santos Moraes I Jr, Madalosso CA, Palma LA, da Silva Fornari AC, do Socorro Dourado M, Scherer T, Gurski RR, Fornari F.

Obes Surg. 2009 Mar;19(3):281-6. doi: 10.1007/s11695-008-9779-1. Epub 2008 Dec 9.

PMID:
19067087
27.

Effect of hyperbaric oxygen therapy on esophagojejunal anastomosis healing in rats.

Lionço JD, Lionço LC, Filippi LT, Lionço CC, Volkweiss B, Gurski RR.

Acta Cir Bras. 2008 Nov-Dec;23(6):491-6.

28.

Heartburn during sleep: a clinical marker of gastro-oesophageal reflux disease in morbidly obese patients.

Fornari F, Madalosso CA, Callegari-Jacques SM, Gurski RR.

Neurogastroenterol Motil. 2009 Feb;21(2):136-42. doi: 10.1111/j.1365-2982.2008.01170.x. Epub 2008 Jul 22.

PMID:
18651868
29.

Performance of the Montreal Consensus in the diagnosis of gastroesophageal reflux disease in morbidly obese patients.

Madalosso CA, Fornari F, Callegari-Jacques SM, Madalosso CA, Gurski RR.

Obes Surg. 2008 Jun;18(6):668-74. doi: 10.1007/s11695-008-9462-6. Epub 2008 Mar 6.

PMID:
18322762
30.

c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

Schmidt MK, Meurer L, Volkweis BS, Edelweiss MI, Schirmer CC, Kruel CD, Gurski RR.

Dis Esophagus. 2007;20(3):212-6.

PMID:
17509117
31.

Extraesophageal manifestations of gastroesophageal reflux disease.

Gurski RR, da Rosa AR, do Valle E, de Borba MA, Valiati AA.

J Bras Pneumol. 2006 Mar-Apr;32(2):150-60. Review. English, Portuguese.

32.

Prevalence of p21 immunohistochemical expression in esophageal adenocarcinoma.

Villwock Mde M, Meurer L, Cavazzola LT, Gurski RR, Edelweiss MI, Schirmer CC.

Arq Gastroenterol. 2006 Jul-Sep;43(3):212-8.

33.

Nutritional assessment in patients with squamous cell carcinoma of the esophagus.

Gurski RR, Schirmer CC, Rosa AR, Brentano L.

Hepatogastroenterology. 2003 Nov-Dec;50(54):1943-7.

PMID:
14696438
34.
35.

Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus.

Rosa AR, Schirmer CC, Gurski RR, Meurer L, Edelweiss MI, Kruel CD.

Dis Esophagus. 2003;16(2):112-8.

PMID:
12823209
36.

Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.

Gurski RR, Peters JH, Hagen JA, DeMeester SR, Bremner CG, Chandrasoma PT, DeMeester TR.

J Am Coll Surg. 2003 May;196(5):706-12; discussion 712-3.

PMID:
12742201
37.

Surveillance and surgery for Barrett's esophagus: more results from Sweden.

Lord RV, Gurski RR.

Am J Gastroenterol. 2002 Aug;97(8):2136-7. No abstract available.

PMID:
12190192
38.

CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism.

Godoy W, Albano RM, Moraes EG, Pinho PR, Nunes RA, Saito EH, Higa C, Filho IM, Kruel CD, Schirmer CC, Gurski R, Lang MA, Pinto LF.

Carcinogenesis. 2002 Apr;23(4):611-6.

PMID:
11960914
39.

Efficacy of computed axial tomography in the evaluation of the involvement of the respiratory tract in patients with squamous cell carcinoma of esophagus.

Schirmer CC, Osvaldt AB, Gurski RR, Xavier RG, Ilha DO, Kruel CD, Brentano L.

Dis Esophagus. 1999;12(3):196-201.

PMID:
10631912
40.

Survival and prognostic factors in patients with resected epidermoid oesophageal carcinoma.

Rosa AR, Gurski RR, Schirmer CC, Brentano L, Kruel CD.

Int Surg. 1999 Jul-Sep;84(3):193-8.

PMID:
10533775
41.
42.

Alternative surgical treatment for complex enterocutaneous fistula.

Schirmer CC, Gurski RR, Gugel FL, Lazzaron AR, Brentano L, Kruel CD.

Int Surg. 1999 Jan-Mar;84(1):29-34.

PMID:
10421014
43.

Laparoscopic approach to wandering spleen: a case report and an update to the question.

Gurski RR, Schirmer CC, Fischer CA, Thofehrn R, Osvaldt AB, Padoin A, Portinho CP, Kruel CD.

Surg Laparosc Endosc. 1998 Oct;8(5):363-5.

PMID:
9799146
44.

The influence of reperitonization on the induction of formation of intraperitoneal adhesions by a polypropylene mesh prosthesis. An experimental study in rats.

Gurski RR, Schirmer CC, Wagner J, Berlim GL, Müller MF, Beck PE, Weidlich J, Teruchkin B, Schwarzbold AV, Leite CS, Tatsch MF, Saueressig M, Edelweiss MI, Kruel CD.

Int Surg. 1998 Jan-Mar;83(1):67-8.

PMID:
9706524
45.

[Neoplasms associated with esophageal epidermoid carcinoma].

Schirmer CC, Gurski R, Castro MA, Madruga GS, Pedroso FL, Kruel CD, Brentano L.

Rev Assoc Med Bras (1992). 1997 Oct-Dec;43(4):335-9. Portuguese.

PMID:
9595747
46.

Delayed cervical anastomosis of the esophagus for esophageal carcinoma.

Gurski RR, Schirmer CC, Toneto JE Jr, Rosa AR, Toniazzo GP, Fasolo GR, Kruel CD, Brentano L.

Int Surg. 1997 Jan-Mar;82(1):56-9.

PMID:
9189804

Supplemental Content

Loading ...
Support Center